Clinical note · #70
Care management
Patient: Robert Thompson · MRN: 987654321 · DOB: 02/12/1952 · Date of service: 10/05/2024 · Provider: Dr. Jane Smith, MD · Facility: Green Valley Skilled Nursing Facility
Total time spent: 58 minutes · Service period: 09/01/2024 – 09/30/2024
Monthly assessment
- COPD: stable symptoms with occasional shortness of breath on exertion. No acute exacerbations during the month. Continued albuterol inhaler as needed (about 2–3 times per day). Pulmonary rehab referral made and scheduled for the following month. Stable, no exacerbations.
- Chronic kidney disease, stage 4: continues to experience fatigue but denies swelling or signs of fluid overload. Stable creatinine (2.8 mg/dL) and eGFR of 28 mL/min. Dietary adherence improving, per patient. Nephrology follow-up next month. Stable, maintaining dietary restrictions.
- Type 2 diabetes mellitus: inconsistently taking insulin as prescribed but improved blood sugar monitoring. Fasting glucose 150–220 mg/dL; HbA1c 8.4%. Insulin adjustments discussed at the monthly check-in, with education reinforced. Suboptimal control, needs medication adjustment and close follow-up.
- Hypertension: BP averaging 145/95 mmHg despite treatment. Amlodipine added during the month; educated on home BP monitoring. Uncontrolled, follow-up required.
- Hyperlipidemia: discontinued atorvastatin due to muscle pain; began ezetimibe. LDL 145 mg/dL. Lifestyle modifications encouraged. Needs further monitoring.
Cumulative time log
| Date | Service provided | Time |
|---|---|---|
| 09/05/2024 | Reviewed lab results (creatinine, eGFR, HbA1c), documented in medical record, contacted nephrology. | 15 min |
| 09/10/2024 | Phone call to discuss blood pressure readings and medication compliance; reinforced education. | 12 min |
| 09/15/2024 | Adjusted diabetes medication regimen, documented changes, updated care plan for glucose management. | 10 min |
| 09/20/2024 | Phone call about COPD symptoms and inhaler use; confirmed rehab referral; documented. | 8 min |
| 09/25/2024 | Reviewed medication list; education on CKD dietary restrictions and monitoring. | 13 min |
Interventions and actions
| Condition | Intervention | Action taken |
|---|---|---|
| COPD | Albuterol as needed; pulmonary rehab referral | Rehab referral scheduled |
| CKD | Dietary restrictions (low sodium, low protein) | Nephrology follow-up next month |
| Diabetes | Adjust insulin regimen | Glargine 24 units HS; sliding-scale Humalog with meals |
| Hypertension | Home BP monitoring; adjust medication | Amlodipine added; educated on home monitoring |
| Hyperlipidemia | Monitor LDL; lifestyle and dietary changes | Ezetimibe started; dietary consultation |
Goals
- Short term (1–3 months): COPD inhaler use no more than 2×/day within 4 weeks; stabilize creatinine within 3 months; daily glucose under 180 mg/dL within 1 month; BP under 140/90 within 4 weeks; LDL under 130 mg/dL within 3 months.
- Long term (6–12 months): prevent COPD decline and exacerbations; delay dialysis; HbA1c under 7.5% in 6 months; maintain BP under 140/90; LDL under 100 mg/dL.
Next steps
Pulmonology, nephrology and endocrinology appointments in 4–6 weeks. Repeat creatinine, eGFR and HbA1c in 3 months. Primary care visit in 30 days to reassess BP, blood sugar and response to new medications.
Dr. Jane Smith, MD · 10/05/2024